Correlation Between 23Andme Holding and UroGen Pharma
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and UroGen Pharma, you can compare the effects of market volatilities on 23Andme Holding and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and UroGen Pharma.
Diversification Opportunities for 23Andme Holding and UroGen Pharma
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 23Andme and UroGen is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and UroGen Pharma go up and down completely randomly.
Pair Corralation between 23Andme Holding and UroGen Pharma
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the UroGen Pharma. In addition to that, 23Andme Holding is 1.74 times more volatile than UroGen Pharma. It trades about -0.16 of its total potential returns per unit of risk. UroGen Pharma is currently generating about -0.19 per unit of volatility. If you would invest 1,288 in UroGen Pharma on December 2, 2024 and sell it today you would lose (342.00) from holding UroGen Pharma or give up 26.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. UroGen Pharma
Performance |
Timeline |
23Andme Holding |
UroGen Pharma |
23Andme Holding and UroGen Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and UroGen Pharma
The main advantage of trading using opposite 23Andme Holding and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics | UroGen Pharma vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |